“…4TI breast cancer cells (ATCC, Manassas, VA), which were radiation and paraplatin sensitive [19,20], and EMT-6 tumors (ATCC, Manassas, VA), which were radiation and paraplatin resistant [21,22], were used in this study. 4TI cells were maintained in RPMI 1640 medium (Gibco N.Y. USA) containing 10% fetal bovine serum (FBS).…”